Mt. Pleasant, SC, United States of America

Suniti Misra


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Mount Pleasant, SC (US) (2012)
  • Mt. Pleasant, SC (US) (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Suniti Misra: Innovator in Cancer Treatment

Introduction

Suniti Misra is a prominent inventor based in Mt. Pleasant, SC (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on addressing multi-drug resistance in cancer cells.

Latest Patents

Suniti Misra's latest patents include methods and compositions for the inhibition of multi-drug resistance by hyaluronan oligomers. These pharmaceutical compositions aim to sensitize multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents. The compositions consist of ligands of hyaluronan receptors, including glycosaminoglycans such as hyaluronan oligomers and their derivatives. Additionally, they incorporate hyaluronan binding proteins, antibodies specific for hyaluronan receptors, hyaluronan mimetics, inhibitors of hyaluronan synthesis, and stimulators of hyaluronan degradation.

Career Highlights

Suniti Misra is affiliated with Tufts University, where she continues her research and development in the field of pharmaceuticals. Her work has garnered attention for its potential to improve treatment outcomes for patients facing multi-drug resistant cancers.

Collaborations

Suniti has collaborated with notable colleagues, including Bryan P. Toole and Shibnath Ghatak. These partnerships have further enhanced her research efforts and contributed to the advancement of cancer treatment methodologies.

Conclusion

Suniti Misra's innovative work in cancer treatment exemplifies the impact of research and invention in addressing critical health challenges. Her contributions through patented methods and compositions are paving the way for more effective therapies for patients battling multi-drug resistant cancers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…